Annual D&A
$31.00 K
-$1000.00-3.13%
December 31, 2023
Summary
- As of February 7, 2025, CYCC annual depreciation & amortization is $31.00 thousand, with the most recent change of -$1000.00 (-3.13%) on December 31, 2023.
- During the last 3 years, CYCC annual D&A has risen by +$11.00 thousand (+55.00%).
- CYCC annual D&A is now -98.34% below its all-time high of $1.86 million, reached on December 31, 2008.
Performance
CYCC Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1000.00
-$1000.00-50.00%
September 30, 2024
Summary
- As of February 7, 2025, CYCC quarterly depreciation & amortization is $1000.00, with the most recent change of -$1000.00 (-50.00%) on September 30, 2024.
- Over the past year, CYCC quarterly D&A has dropped by -$7000.00 (-87.50%).
- CYCC quarterly D&A is now -99.93% below its all-time high of $1.52 million, reached on December 31, 2008.
Performance
CYCC Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$13.00 K
-$6000.00-31.58%
September 30, 2024
Summary
- As of February 7, 2025, CYCC TTM depreciation & amortization is $13.00 thousand, with the most recent change of -$6000.00 (-31.58%) on September 30, 2024.
- Over the past year, CYCC TTM D&A has dropped by -$18.00 thousand (-58.06%).
- CYCC TTM D&A is now -99.48% below its all-time high of $2.50 million, reached on June 30, 2009.
Performance
CYCC TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
CYCC Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.1% | -87.5% | -58.1% |
| 3 y3 years | +55.0% | -87.5% | -58.1% |
| 5 y5 years | +6.9% | -87.5% | -58.1% |
CYCC Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.9% | at low | -88.9% | at low | -69.8% | at low |
| 5 y | 5-year | -27.9% | +55.0% | -94.1% | at low | -69.8% | at low |
| alltime | all time | -98.3% | +55.0% | -99.9% | +100.3% | -99.5% | +106.3% |
Cyclacel Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1000.00(-50.0%) | $13.00 K(-31.6%) |
| Jun 2024 | - | $2000.00(0.0%) | $19.00 K(-24.0%) |
| Mar 2024 | - | $2000.00(-75.0%) | $25.00 K(-19.4%) |
| Dec 2023 | $31.00 K(-3.1%) | $8000.00(+14.3%) | $31.00 K(0.0%) |
| Sep 2023 | - | $7000.00(-12.5%) | $31.00 K(0.0%) |
| Jun 2023 | - | $8000.00(0.0%) | $31.00 K(0.0%) |
| Mar 2023 | - | $8000.00(0.0%) | $31.00 K(-3.1%) |
| Dec 2022 | $32.00 K(-25.6%) | $8000.00(+14.3%) | $32.00 K(+3.2%) |
| Sep 2022 | - | $7000.00(-12.5%) | $31.00 K(-8.8%) |
| Jun 2022 | - | $8000.00(-11.1%) | $34.00 K(-20.9%) |
| Mar 2022 | - | $9000.00(+28.6%) | $43.00 K(0.0%) |
| Dec 2021 | $43.00 K(+115.0%) | $7000.00(-30.0%) | $43.00 K(+7.5%) |
| Sep 2021 | - | $10.00 K(-41.2%) | $40.00 K(+11.1%) |
| Jun 2021 | - | $17.00 K(+88.9%) | $36.00 K(+50.0%) |
| Mar 2021 | - | $9000.00(+125.0%) | $24.00 K(+20.0%) |
| Dec 2020 | $20.00 K(0.0%) | $4000.00(-33.3%) | $20.00 K(-4.8%) |
| Sep 2020 | - | $6000.00(+20.0%) | $21.00 K(+5.0%) |
| Jun 2020 | - | $5000.00(0.0%) | $20.00 K(+5.3%) |
| Mar 2020 | - | $5000.00(0.0%) | $19.00 K(-5.0%) |
| Dec 2019 | $20.00 K(-31.0%) | $5000.00(0.0%) | $20.00 K(-9.1%) |
| Sep 2019 | - | $5000.00(+25.0%) | $22.00 K(-8.3%) |
| Jun 2019 | - | $4000.00(-33.3%) | $24.00 K(-14.3%) |
| Mar 2019 | - | $6000.00(-14.3%) | $28.00 K(-3.4%) |
| Dec 2018 | $29.00 K(-9.4%) | $7000.00(0.0%) | $29.00 K(0.0%) |
| Sep 2018 | - | $7000.00(-12.5%) | $29.00 K(-3.3%) |
| Jun 2018 | - | $8000.00(+14.3%) | $30.00 K(0.0%) |
| Mar 2018 | - | $7000.00(0.0%) | $30.00 K(-6.3%) |
| Dec 2017 | $32.00 K(-75.9%) | $7000.00(-12.5%) | $32.00 K(-34.7%) |
| Sep 2017 | - | $8000.00(0.0%) | $49.00 K(-34.7%) |
| Jun 2017 | - | $8000.00(-11.1%) | $75.00 K(-25.0%) |
| Mar 2017 | - | $9000.00(-62.5%) | $100.00 K(-24.8%) |
| Dec 2016 | $133.00 K(-36.7%) | $24.00 K(-29.4%) | $133.00 K(-17.9%) |
| Sep 2016 | - | $34.00 K(+3.0%) | $162.00 K(-11.5%) |
| Jun 2016 | - | $33.00 K(-21.4%) | $183.00 K(-8.5%) |
| Mar 2016 | - | $42.00 K(-20.8%) | $200.00 K(-4.8%) |
| Dec 2015 | $210.00 K(+20.7%) | $53.00 K(-3.6%) | $210.00 K(-2.8%) |
| Sep 2015 | - | $55.00 K(+10.0%) | $216.00 K(-6.1%) |
| Jun 2015 | - | $50.00 K(-3.8%) | $230.00 K(+13.3%) |
| Mar 2015 | - | $52.00 K(-11.9%) | $203.00 K(+16.7%) |
| Dec 2014 | $174.00 K(+148.6%) | $59.00 K(-14.5%) | $174.00 K(+37.0%) |
| Sep 2014 | - | $69.00 K(+200.0%) | $127.00 K(+58.8%) |
| Jun 2014 | - | $23.00 K(0.0%) | $80.00 K(+19.4%) |
| Mar 2014 | - | $23.00 K(+91.7%) | $67.00 K(-4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $70.00 K(+16.7%) | $12.00 K(-45.5%) | $70.00 K(-4.1%) |
| Sep 2013 | - | $22.00 K(+120.0%) | $73.00 K(+10.6%) |
| Jun 2013 | - | $10.00 K(-61.5%) | $66.00 K(-7.0%) |
| Mar 2013 | - | $26.00 K(+73.3%) | $71.00 K(+18.3%) |
| Dec 2012 | $60.00 K(-91.0%) | $15.00 K(0.0%) | $60.00 K(-129.3%) |
| Sep 2012 | - | $15.00 K(0.0%) | -$205.00 K(+44.4%) |
| Jun 2012 | - | $15.00 K(0.0%) | -$142.00 K(+100.0%) |
| Mar 2012 | - | $15.00 K(-106.0%) | -$71.00 K(<-9900.0%) |
| Dec 2011 | - | -$250.00 K(-420.5%) | $0.00(-100.0%) |
| Sep 2011 | - | $78.00 K(-9.3%) | -$101.00 K(+48.5%) |
| Jun 2011 | - | $86.00 K(0.0%) | -$68.00 K(+61.9%) |
| Mar 2011 | - | $86.00 K(-124.5%) | -$42.00 K(<-9900.0%) |
| Dec 2010 | - | -$351.00 K(-416.2%) | $0.00(-100.0%) |
| Sep 2010 | - | $111.00 K(-0.9%) | $518.00 K(+70.4%) |
| Jun 2010 | - | $112.00 K(-12.5%) | $304.00 K(-50.2%) |
| Mar 2010 | - | $128.00 K(-23.4%) | $610.00 K(-8.7%) |
| Dec 2009 | $668.00 K(-64.1%) | $167.00 K(-262.1%) | $668.00 K(-66.9%) |
| Sep 2009 | - | -$103.00 K(-124.6%) | $2.02 M(-19.4%) |
| Jun 2009 | - | $418.00 K(+124.7%) | $2.50 M(+15.8%) |
| Mar 2009 | - | $186.00 K(-87.7%) | $2.16 M(+16.0%) |
| Dec 2008 | $1.86 M(+522.7%) | $1.52 M(+297.9%) | $1.86 M(+1078.5%) |
| Sep 2008 | - | $381.00 K(+401.3%) | $158.00 K(-290.4%) |
| Jun 2008 | - | $76.00 K(-168.5%) | -$83.00 K(+151.5%) |
| Mar 2008 | - | -$111.00 K(-41.0%) | -$33.00 K(-111.0%) |
| Dec 2007 | $299.00 K(-72.7%) | -$188.00 K(-234.3%) | $299.00 K(-58.7%) |
| Sep 2007 | - | $140.00 K(+11.1%) | $724.00 K(-13.2%) |
| Jun 2007 | - | $126.00 K(-43.0%) | $834.00 K(-20.0%) |
| Mar 2007 | - | $221.00 K(-6.8%) | $1.04 M(-4.8%) |
| Dec 2006 | $1.09 M(-17.2%) | $237.00 K(-5.2%) | $1.09 M(-4.2%) |
| Sep 2006 | - | $250.00 K(-25.1%) | $1.14 M(-5.5%) |
| Jun 2006 | - | $334.00 K(+21.9%) | $1.21 M(-1.1%) |
| Mar 2006 | - | $274.00 K(-3.9%) | $1.22 M(-7.5%) |
| Dec 2005 | $1.32 M(+1.2%) | $285.00 K(-9.8%) | $1.32 M(+2.6%) |
| Sep 2005 | - | $316.00 K(-9.2%) | $1.29 M(-2.4%) |
| Jun 2005 | - | $348.00 K(-6.7%) | $1.32 M(-2.0%) |
| Mar 2005 | - | $373.00 K(+48.0%) | $1.35 M(+3.2%) |
| Dec 2004 | $1.31 M(+40.6%) | $252.00 K(-27.6%) | $1.31 M(-3.2%) |
| Sep 2004 | - | $348.00 K(-7.2%) | $1.35 M(+12.0%) |
| Jun 2004 | - | $375.00 K(+13.3%) | $1.21 M(+15.4%) |
| Mar 2004 | - | $331.00 K(+12.2%) | $1.04 M(+12.4%) |
| Dec 2003 | $929.00 K | $295.00 K(+44.6%) | $929.00 K(+46.5%) |
| Sep 2003 | - | $204.00 K(-4.7%) | $634.00 K(+47.4%) |
| Jun 2003 | - | $214.00 K(-0.9%) | $430.00 K(+99.1%) |
| Mar 2003 | - | $216.00 K | $216.00 K |
FAQ
- What is Cyclacel Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals annual D&A year-on-year change?
- What is Cyclacel Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly D&A year-on-year change?
- What is Cyclacel Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals TTM D&A year-on-year change?
What is Cyclacel Pharmaceuticals annual depreciation & amortization?
The current annual D&A of CYCC is $31.00 K
What is the all time high annual D&A for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual depreciation & amortization is $1.86 M
What is Cyclacel Pharmaceuticals annual D&A year-on-year change?
Over the past year, CYCC annual depreciation & amortization has changed by -$1000.00 (-3.12%)
What is Cyclacel Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of CYCC is $1000.00
What is the all time high quarterly D&A for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly depreciation & amortization is $1.52 M
What is Cyclacel Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, CYCC quarterly depreciation & amortization has changed by -$7000.00 (-87.50%)
What is Cyclacel Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of CYCC is $13.00 K
What is the all time high TTM D&A for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high TTM depreciation & amortization is $2.50 M
What is Cyclacel Pharmaceuticals TTM D&A year-on-year change?
Over the past year, CYCC TTM depreciation & amortization has changed by -$18.00 K (-58.06%)